Elon Musk’s Neuralink has achieved a significant advancement in brain technology by successfully implanting its brain-computer interface into a human.
Musk made the announcement on social media platform X, disclosing that the process occurred during the weekend. The first recipient is reportedly “recovering well,” although details about the person remain undisclosed.
Table of Contents
Positive Early Signs In Neuron Spike Detection
Early feedback from the implanted brain-computer interface is positive, particularly in the realm of neuron spike detection. This aspect is crucial for the device’s functionality. While there is little detail about the identity of the recipient, Elon Musk seemed to be optimistic about the results of the first phase of the process.
Neuralink’s Allocation Of Solving Brain Disorders.
The mission of Neuralink is focused on brain disorders and injuries. The company had in the past shown its commitment to recruit quadriplegia or ALS patients for its trials. Neuralink is a clear leader in the neurotechnology sector, given the background of more than 40 brain-computer interface trials and trials taking place worldwide.
Neuralink received an “investigational device exemption” from the US Food and Drug Association (FDA), thus enabling clinical trials. However, the FDA has maintained confidentiality regarding specific study details. Neuralink’s device, approximately the size of a large coin, is designed for implantation in the skull, featuring ultra-thin wires directly connected to the brain.
The company aims to target the brain region controlling movement intention, initially enabling individuals to control computers through their thoughts alone. The device, named “Telepathy” by Musk, is poised to empower users, especially those who have lost limb functionality, to control phones or computers through mere thoughts.
Safety Concerns And Questions Surrounding “Telepathy”
While the announcement of Neuralink’s successful implantation is met with intrigue, questions and skepticism persist. Laura Cabrera, a brain science researcher at Pennsylvania State University, highlighted the inherent risks associated with brain surgery.
She emphasized potential complications such as brain hemorrhage or seizures despite acknowledging Neuralink’s innovative use of robotic surgery for implantation. Cabrera highlighted the uncertainties about the safety of the procedure for humans and the peril of the leap to the unknown.
However, the revelation of “Telepathy” has initiated debates on the safety and performance of the device, with the search for consequences of Neuralink’s grandiose project to enter the world of brain-computer interfaces continuing.